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The maturation of c-type cytochromes requires the covalent liga-
tion of the heme cofactor to reduced cysteines of the CXXCH motif
of apocytochromes. In contrast to mitochondria of other eu-
karyotes, plant mitochondria follow a pathway close to that found
in - and -proteobacteria. We identified a nuclear-encoded pro-
tein, AtCCMH, the Arabidopsis thaliana ortholog of bacterial
CcmHCycL proteins. In bacteria, CcmH and the thioredoxin CcmG
are components of a periplasmic thio-reduction pathway proposed
to maintain the apocytochrome c cysteines in a reduced state.
AtCCMH is located exclusively in mitochondria. AtCCMH is an
integral protein of the inner membrane with the conserved RCXXC
motif facing the intermembrane space. Reduction assays show that
the cysteine thiols in the RCXXC motif of AtCCMH can form a
disulfide bond that can be reduced by enzymatic thiol reductants.
A reduced form of AtCCMH can reduce the intra-disulfide bridge of
a model peptide of apocytochrome c. When expressed in Esche-
richia coli, AtCCMH coimmunoprecipitates with the bacterial CcmF,
a proposed component of the heme lyase. Blue-native PAGE of
mitochondrial membrane complexes reveals the colocalization of
AtCCMH and AtCcmFN2 in a 500-kDa complex. Yeast two-hybrid
assays show an interaction between the AtCCMH intermembrane
space domain and A. thaliana apocytochrome c. A. thaliana ccmh
ccmh knockout plants show lethality at the torpedo stage of
embryogenesis. Our results show that AtCCMH is an essential
mitochondrial protein with characteristics consistent with its pro-
posed apocytochrome c-reducing and heme lyase function.
plant mitochondria  cytochrome c  disulfide reductase  heme lyase 
embryo-lethal
Type c cytochromes are hemoproteins that play an essential rolein respiratory and photosynthetic electron transport. In pro-
karyotes and eukaryote organelles, they function on the so-called
p-side of the energy-transducing membranes. They are character-
ized by the covalent ligation of two vinyl groups of the prosthetic
heme to the two cysteines within the CXXCH motif of apocyto-
chromes. The genetic analysis of c-type cytochrome maturation in
bacteria, mitochondria, and chloroplasts has led to the identifica-
tion of three different biogenesis pathways, referred to as systems
I, II, and III (1–3). The transport of both heme and apocytochrome
c to their site of activity and their maintenance in reduced state are
common requirements for the assembly of holocytochromes c in the
three systems.
Earlier studies in yeast (system III) showed cytochrome c and
cytochrome c1 heme lyases (CCHL and CCHL1) to be the central
players in the formation of mitochondrial cytochrome c and c1 (4,
5). Orthologs of CCHL genes are found in nuclear genomes of
vertebrates, invertebrates, and some green algae (i.e., Chlamydo-
monas reinhardtii), suggesting that their mitochondrial c-type cyto-
chromes are assembled through system III.
In contrast, system I seems more complex. In Escherichia coli,
eight ccm genes (for cytochrome c maturation) arranged in an
operon (6) and three dsb genes (for disulfide bond formation) are
essential for the production of holocytochrome c (7, 8). CcmA and
CcmB are components of an ATP-binding cassette transporter
whose substrate is not known (9, 10). CcmCDE are involved in
heme delivery. CcmC is required for the covalent attachment of
heme to the heme chaperone CcmE (10–12). CcmF has been
proposed to form a bacterial cytochrome c heme lyase complex
togetherwithCcmH(13). Cysteine thiols of the heme-bindingmotif
of apocytochromes c are oxidized by the periplasmic DsbA. CcmG,
a thioredoxin-like protein, and CcmH, a putative thiol-disulfide
oxidoreductase, reduce intramolecular disulfide bonds in apocyto-
chromes before heme attachment by transferring electrons from the
transmembrane disulfide oxidoreductase DsbD (DipZ) (14, 15). In
bacteria, the loss ofCcmH(CycLCcl2) results in either the absence
of any detectable c-type cytochromes (2, 6) or reduced levels of
c-type cytochromes (16, 17). CcmH proteins possess an RCXXC
motif exposed to the periplasm. This motif is believed to be active
in the reduction of the cysteines of the CXXCH motif on apocy-
tochromes c (18, 19). Because in fungal and animal mitochondria
system III is used for cytochromes cmaturation, the occurrence of
bacterial system I ccm orthologs in plant mitochondrial genomes
was unexpected. Orthologs of ccmB, ccmC, and ccmF have been
found in all embryophyte mitochondrial genomes studied so far. In
Arabidopsis thaliana, three genes encode proteins similar to differ-
ent domains of CcmF (20). The study of the A. thaliana genomic
sequence has led to the identification of nuclear-encoded CCM
components: the heme chaperone AtCCME (21) and the ATP-
binding domain of the ABC transporter AtCCMA (N.R., unpub-
lished data). Here, we identify AtCCMH and investigate its func-
tion as a mitochondrial thiol-disulfide oxidoreductase and a
component of a heme lyase complex involved in cytochrome c
maturation.
Materials and Methods
Overexpression of AtCCMH and Antibody Production. The 5 part of
AtCCMH cDNA (corresponding to M1-Q84) was amplified by
PCR by using P1 and P2 primers (for primer sequences, see List 1,
which is published as supporting information on thePNASweb site)
and cloned in pQE60 (Qiagen, Valencia, CA). The His-tag fusion
protein (D1-His) was expressed inE. coli, purified under denaturing
conditions, and injected into rabbits. Sera were purified against
D1-His coupled to CnBr-activated Sepharose according to the
supplier’s instructions (Amersham Pharmacia Biotech). A. thaliana
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CcmFN2-specific antibodies were raised against the peptide
MKQQASVRRTYKKEM coupled with ovalbumin (N.R., unpub-
lished data).
Coexpression of AtCCMH and EcCcm Proteins. We have constructed
the plasmid pEM19, which encodesE. coliCcmA-G and a chimeric
CcmH consisting of EcCcmH (M1-T19)::AtCCMH (D5-R159 
His-tag) for complementation experiment in E. coli ccm strain
EC06 (see Supporting Materials and Methods, which is published as
supporting information on the PNAS web site). For coimmuno-
precipitation experiments, 500 g of E. coli membrane proteins
were solubilized and precipitated with 5l of anti-CcmF antibodies
(13) according to previous work (12). E. coli spheroplasts were
prepared by treatment with 8 gml lysozyme in 100 mM TrisHCl
(pH 8.0) containing 20% sucrose.
Purification of A. thaliana Mitochondria and Chloroplasts, Mitoplast
Preparation, and Submitochondrial Fractionation. A. thaliana proto-
plasts were prepared from 5-day-old suspension cell culture (22).
Mitochondria and chloroplast purification on Percoll step gradient,
mitoplast preparation, submitochondrial fractionation, proteinase
K, and alkali treatments were performed as described (21).
Solubilization of Mitochondrial Complexes and Separation on Two-
Dimensional Blue-Native-SDSPAGE. Four hundred micrograms of
mitochondrial membrane proteins were solubilized with digitonin,
5:1 detergent:protein (wtwt) for 30 min on ice. Mitochondrial
membrane complexes were resolved by blue-native PAGE in the
first dimension followed by SDSPAGE in the second dimension as
described (23).
Arabidopsis Lines. The A. thaliana ccmhmutant was obtained from
the SALK T-DNA (transferred DNA) insertion lines collection
(24). Seeds from WT (Columbia) or mutant (SALK046872) were
sown on Murashige and Skoog medium or soil and grown under
16-h light8-h dark cycles at 22°C20°C.
Microscopy. Seeds were removed from siliques, fixed in 2% glutar-
aldehyde, and treated with Hoyer’s solution (25). Embryos were
observed by differential interference contrast (DIC) microscopy
with a Nikon E800 microscope. Isolated embryos were fixed in 2%
glutaraldehyde, stained, dehydrated, and included in Epon 812 as
described (26). Observations of 90-m-thick sections were per-
formed with a Hitachi H600 transmission electron microscope at a
tension of 75,000 volts.
Thiol Titration and in Vitro Redox Assay. D1-His was expressed in
E. coli and purified under native conditions. The thiol content of
D1-His was measured by using a 5,5-dithiobis-2-nitrobenzoic acid
(DTNB) assay as follows. D1-His (100 mol) was reduced with 10
mM DTT for 10 min at room temperature. DTT was removed by
buffer exchange by using a 10-kDa cutoff filtration membrane.
Resulting thiols were labeled with 1 mMDTNB for 30 min. DTNB
in excess was removed by using centrifugal filter devices. Procedures
for the expression and purification of A. thaliana NADPH thiore-
doxin reductase B (AtNTRB), poplar thioredoxin h1 and h2 (Pt-
TRXh1, PtTRXh2), and glutaredoxin (PtGRX) are described else-
where (27–30). AtNTRB and PtTRXh2 are mitochondrial proteins
(29, 31). Interactions between labeled D1-His (6 M) and disulfide
reductants were performed in 30 mM TrisHCl buffer (pH 8.0) by
measuring the release of thionitrobenzoic acid (TNB) after 30min
at 412 nm (412  13,600 M1cm1). Thioredoxins (50 M) and
glutathione (35 M) were reduced by using catalytic amounts of
NTR (0.8 M) and glutathione reductase (0.5 UI, Sigma), respec-
tively, in the presence of 250 MNADPH. Glutaredoxin was used
at a concentration of 50M.The peptide FRTKCAQCHTVEused
as a model for A. thaliana apocytochrome c-a (At1g22840) was
synthesized and oxidized with DMSO (NeoMPS, Strasbourg,
France). The predicted molecular mass of the peptide with an
intra-disulfide bridge (1,420Da) was verified bymass spectrometry.
Equimolar amounts (85 M) of oxidized peptide and reduced
D1-His were incubated for 1 hr at 20°C and separated on a C4
column by using a Waters HPLC system. Mass measurement was
carried out on a Biflex III (Bruker-Daltonik, Ettlingen, Germany)
MALDI-TOF mass spectrometer used in reflector-positive mode.
Yeast Two-Hybrid Assays. cDNA fragments coding for D1 (M1-
Q84) and D2 (Y105-R159) domains of AtCCMH, as well as for
the full-length cytochrome c-a gene (C), were amplified with
primers P7 and P8 for D1, P9 and P10 for D2, and P11 and P12
for C, then reamplified with universal primers P13 and P14 to
introduce phage lambda att recombination sites. The products
obtained were recombined with pDONR207 donor vectors by
using Gateway technology (Invitrogen) to obtain entry vectors.
These vectors were recombined with Clontech pGBKT7- and
pGADT7-modified vectors (32) to obtain vectors expressing all
of the combinations of fusion proteins. Constructs were trans-
formed in yeast strain pJ69-4A by heat shock. Two-hybrid assays
were performed according to standard methods (33). Transfor-
mation in yeast was controlled by the growth on media lacking
leucine and tryptophan. The expression of the reporter genes
ADE2 and HIS3 was monitored by the growth on media lacking
adenine, histidine, and both. The expression of lacZwas followed
by measuring at OD420 the accumulation of the product metab-
olized by -galactosidase with 2.2 mM 2-nitrophenyl -D-
galactopyranoside (o-NPG, Sigma) as substrate.
Results
Identification and Expression of AtCCMH. We have identified a
single-copy gene present onA. thaliana chromosome 1 (At1g15220)
encodes a protein showing 20–25% identity with Bradyrhizobium
japonicum CycL, Rhodobacter capsulatus Ccl2, Rhodobacter spha-
eroides CcmH, and the N-terminal half of E. coli CcmH. In
eukaryotes, orthologs of ccmH are found in nuclear genomes of
angiosperms and gymnosperms and of the unicellular primitive red
alga Cyanidioschyzon merolae. Up to now, no ccmH ortholog is
found in protists, green algae, or mosses. EST data revealed high
conservation of CCMH proteins among the plant species (60–90%
identity). The reduced number of ESTs found and the absence of
detection of AtCCMH transcripts by Northern experiments reflect
a low level of expression. By RT-PCR experiments, we found that
the gene is expressed in all A. thaliana organs and that its three
introns are spliced (data not shown). Themature transcript encodes
a protein of 159 aa composed of two hydrophilic domains, D1 and
D2, separated by a hydrophobic domain (Fig. 1). The N-terminal
signal sequence responsible for targeting the bacterial CycL to the
periplasm is not conserved in plant proteins. Instead, AtCCMHhas
a C-terminal extension not found in bacterial proteins. The poten-
tial thiol-disulfide oxidoreductase motif (RCXXC) is located in the
N-terminal D1 domain.
AtCCMH Is Localized in the Mitochondrial Inner Membrane. The
cellular localization ofAtCCMHcould not be predicted because no
organellar N-terminal targeting sequence could be identified. The
anti-AtCCMH antibodies generated against D1 recognized a
unique protein in total protoplast extract prepared fromA. thaliana
cells, with an apparent molecular mass of 20 kDa, close to the
calculated 17.9 kDa (Fig. 2A). The protein was found in the purified
mitochondrial fraction and was absent in both cytosolic and chlo-
roplastic protein fractions.
Bacterial CcmH proteins are inserted into the cytoplasmic mem-
brane with their N-terminal domain localized in the periplasm (18,
19). Mitochondrial subfractions were analyzed to check AtCCMH
location and topology. No signal was detected with the outer
membrane fraction, whereasAtCCMHwas immunodetected in the
inner membrane fraction (Fig. 2 B andC). The nature of AtCCMH
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interaction with the inner membrane was investigated by alkali
solubilization. Like CYTc1, a protein with a transmembrane helix,
AtCCMH remained in the insoluble fraction whereas Nad9 was
found in the extrinsic protein fraction (Fig. 2D). We propose that
the hydrophobic domain present in AtCCMH is a transmembrane
domain. The orientation of the protein predicted to follow the
N-out and C-in model was investigated by treating intact mitoplasts
with proteinase K. The inner membrane integrity was controlled by
Nad9 detection. After the protease treatment, the signal obtained
with antibodies raised against D1 was strongly reduced, thus
confirming the localization of that domain (containing theRCXXC
motif) in the mitochondrial intermembrane space (Fig. 2E).
AtCCMH Is Essential for Embryo Development. To gain insights into
the function of AtCCMH, we analyzed an A. thaliana insertion line
(SALK046872) carrying a transferred DNA (T-DNA) in the
second intron. No homozygous plants for the insertion could be
identified by PCR analysis, suggesting that this mutation is lethal in
its homozygote state. No phenotype could be evidenced after
careful observation of four individual heterozygous ccmhCCMH
plants at different stages of development. The observed kanR
segregation ratio of 2:1 of their progeny indicated that there is only
one insertion site and that lethality of ccmhccmh homozygotes is
embryonic. We dissected siliques of self-fertilized ccmhCCMH
andWTplants at different stages of development.Although, inWT
siliques, seeds were of uniform color, size, and shape, ccmhCCMH
immature siliques observed 7 days post-fecundation contained 25%
of smaller sized pale seeds that aborted and shrank at later
developmental stages (Fig. 3A). The embryos from these abnormal
seeds were dissected out of the mother seed tissue. PCR analysis
showed that these embryos were homozygous (ccmhccmh) for the
insertion in AtCCMH (Fig. 6, which is published as supporting
information on the PNAS web site). The effect of AtCCMH
deficiency on A. thaliana embryo development was examined by
comparing embryos isolated from the two types of seeds obtained
from the same silique. Although green seeds contained embryos at
the cotyledon stage, ccmhccmh embryos were arrested at the
torpedo and occasionally heart stages without visible abnormality
in the morphogenesis (Fig. 3 B and C). Embryos at the torpedo
stage were examined by transmission electron microscopy to inves-
tigate cell differentiation and ultrastructure. Cotyledon cells ofWT
or heterozygote mature embryo had a regular shape and started to
differentiate (Fig. 3D). Nuclei with a nucleolus, chloroplasts, and
mitochondria were clearly identified. Storage bodies had a round or
Fig. 2. Localization of AtCCMH. Protein fractions from A. thaliana were
analyzed by Western blots probed with antibodies directed against AtCCMH.
(A) Protein extracts (20 g) of protoplasts (Pr), cytosol (Cy), chloroplasts (Ch),
and mitochondria (Mt). (B) Mitochondrial (Mt), mitoplast (Mtp), and outer
membrane (OM) fractions were purified on gradients. (C) Matrix (Ma) and
inner membrane (IM) fractions were prepared from broken mitoplasts. (D)
Peripheral proteins (IMp) and integral membrane proteins (IMi) were ob-
tained after alkali treatment of IM. (E) Mitoplasts were treated with protein-
ase K (Mtp K). Controls were performed by using antibodies directed against
the chloroplast large subunit of RuBisCo (LSU), a cytosolic thioredoxin (TRX3),
a peripheral protein of complex I oriented toward the matrix (Nad9), a subunit
of the translocase of the outer membrane (TOM40), the matrix manganese
superoxide dismutase (MnSOD), and cytochrome c1 (CYTc1), an integral pro-
tein of complex III.
Fig. 1. Amino acid sequence alignment of CCMHCycLCcl2
proteins from different organisms: Arabidopsis thaliana
(Arath), Orysa sativum (Orysa), Escherichia coli (Ecoli, CcmH
partial sequence, M1-I154), Pseudomonas fluorescens (Psefl),
Rhodobacter capsulatus (Rhoca), Bradyrhizobium japonicum
(Braja). Residues identical in more than three sequences are
highlighted in black whereas similar residues are highlighted
in light gray. The hydrophobic domain is boxed. Arrows indi-
cate D1 and D2 hydrophilic domains. The conserved RCXXC
motif is underlined.
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ovoid shape. On the other hand, mutant cotyledon cells had an
irregular shape, with abnormal cell wall and an enlarged intercel-
lular space (Fig. 3E). The cell content was completely disorganized,
with no organelles, a denser cytosol, and smaller and more abun-
dant storage bodies. The defect in CCMH resulted in the arrest of
embryo development due to severe cellular disorder, which strongly
suggests that AtCCMH is an essential gene encoding a housekeep-
ing function.
AtCCMH Expressed in E. coli Interacts with EcCcmF. In E. coli, CcmH
is a bipartite protein with domains corresponding to B. japonicum
CycL and CycH proteins (1). The CycL domain containing the
conserved RCXXC motif is required to synthesize c-type cyto-
chromes whereas the CycH domain is not (19). To check whether
AtCCMH could replace EcCcmH, an E. coli ccm strain (EC06)
was transformed with pEM19, which contains a modified E. coli
ccm operon in which AtCCMH was transitionally fused with the
sequence coding for the periplasm-targeting peptide of EcCcmH
and a C-terminal His-tag. The expression of AtCCMH in bacteria,
as well as the insertion into the cytoplasmic membrane with a
correct topology, was observed (Fig. 7, which is published as
supporting information on thePNASweb site).Noholocytochrome
c550 could be detected by heme staining of periplasmic proteins,
whereas the WT ccm operon allowed the formation of mature
c-type cytochromes (data not shown) as reported for the E. coli
operon containing a truncated CycL-like EcCcmH (19). Thus,
AtCCMH is unable to complement the lack of its E. coli counter-
part. Because E. coli CcmH forms a complex with CcmF (13), we
used the complementation assay to check whether a heterologous
interaction occurs in vivo between AtCCMH and EcCcmF. A
membrane extract was solubilized and immunoprecipitated by
using antibodies directed against EcCcmF, and indeed AtCCMH
was found to coimmunoprecipitate with EcCcmF (Fig. 7).
AtCCMH and AtCcmFN2 Are Found in a 500-kDa Complex. In
A. thaliana, the main conserved domain of CcmF proteins, includ-
ing the ‘‘WWD’’ motif (2), is encoded by the mitochondrial ccmFN2
gene. The association of CCMH with CcmFN2 was investigated by
immunodetection of mitochondrial membrane complexes solubi-
lized with digitonin and separated by blue-native PAGE (34). In the
first dimension, both anti-CCMH and anti-CcmFN2 antibodies
detected a 500-kDa complex (Fig. 4A). The analysis of the second
denaturing dimension, reveals that the 30-kDa CcmFN2 is present
in an additional complex of 700 kDa. TheCCMHantibody detected
a continuous signal between 450 and 650 kDa, with a main signal
of 500 kDa (Fig. 4B). These results strongly suggest that CCMHand
CcmFN2 can be associated in a same protein complex, although this
association does not seem to occur systematically.
AtCCMH Interacts with AtCYTc-a. The proposed roles of CcmH, i.e.,
the reduction of apocytochrome cysteines and heme ligation (to-
gether with CcmF), imply an interaction with apocytochromes. So
far, c-type apocytochromes had never been reported to interact
with any Ccm proteins. We used the yeast two-hybrid system to
investigate whether an interaction between AtCCMH and apocy-
tochrome c could take place. For this purpose, the sequences coding
for AtCYTc-a, an A. thaliana cytochrome c (C), and the sequences
coding for D1 and D2 domains of AtCCMH (Fig. 1) were cloned
in two-hybrid vectors in fusionwith the activation domain (AD) and
the DNA binding domain (BD) of the transcription factor Gal4.
Protein interactions were assayed by growth on selective medium
due to the activation of the nutritional reporter genes ADE2 and
HIS3. Growth was observed for both D1-C combinations, but only
background growth (onmedium lacking adenine or histidine) or no
growth at all (on medium lacking both adenine and histidine) was
observed for the D2-C combinations (Fig. 5A). This result shows
that AtCCMH can indeed interact with cytochrome c and that, as
Fig. 3. Phenotype of ccmhccmh seeds and embryos. (A) Immature silique
from a self-fertilized CCMHccmh plant. Asterisks indicate white seeds with
ccmhccmh embryos. (B and C) Microscopical images of seeds distained with
Hoyer’s solution. Shown are phenotypic WT embryo at mature cotyledon
stage (B) and white immature seeds containing a ccmh embryo arrested at
torpedo stage from the same silique as B (C). (D and E) Electron micrograph of
cotyledon cells from green embryo (D) and white embryo (E). (Scale bars, 200
m in B and C and 2 m in D and E.)
Fig. 4. Association of CCMH with CcmFN2 investigated by blue-native (BN)-
PAGE. The BN gel of mitochondrial protein complexes solubilized with digi-
tonin (A) and the corresponding denaturing second dimension gel (B) were
blotted and reacted with antibodies directed against CcmFN2 and CCMH. The
molecular mass standard is given in kDa. Position and size in kDa of respiratory
complexes I, V, and III are shown above the BN-PAGE. The gray arrow indicates
the 500-kDa protein complex.
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predicted, D1 located in the inter-membrane space can interact
with apocytochrome c, whereas D2, oriented toward the matrix,
cannot. As a control, the six single constructs were cotransformed
in yeast with the corresponding empty vectors (e.g., D1-AD with
empty BD). The absence of growth showed that the activation of
reporter genes was a true reflection of D1 interaction with apocy-
tochrome c (Fig. 5A). The interaction was quantified by the
activation of lacZ, a third reporter gene. Background levels were
estimated in WT yeast cells. The signal resulting from the interac-
tion of cytochrome c with D1 was found to be 10 times higher than
background levels, whereas, with D2, -gal activity never raised
above background levels (Fig. 5B).
In Vitro Redox Properties of AtCCMH. The recombinant D1-His
polypeptide contains the only two cysteines of AtCCMH located in
the presumed catalytic RCXXCmotif. When D1-His, expressed in
E. coli and purified under native conditions, was reduced by a DTT
excess (100-fold), 2 mol of thiol per mol of protein are found by
using DTNB, whereas only 0.6 mol of thiol per mol has been
titrated on untreated protein.Onnonreducing PAGE, recombinant
D1-His appeared mainly as monomers; this result suggests that the
cysteinyl residues can form an intramolecular disulfide bridge in
AtCCMH.DTT-reducedD1-His has been labeled with DTNB and
then submitted to different disulfide reductases (Table 1). NTR-
reduced thioredoxins h1 and h2, which differ at least by their
catalytic site (WCPPC and WCGPC, respectively), are able to
interact with the labeled AtCCMH cysteines releasing thionitro-
benzoic acid (TNB). Addition of glutaredoxin enhanced the
TNB release observed in the presence of both glutathione and
glutathione reductase.
The ability of AtCCMH to reduce apocytochrome c was tested
in an experiment involving the reduced D1-His and a 12-aa
synthetic peptide identical to AtCYTc-a F19-E30 containing an
intramolecular disulfide. After incubation and reverse phase chro-
matography with a wateracetonitrile gradient, two peaks corre-
sponding to the model peptide were eluted. MALDI mass mea-
surement in reflector-positive mode detected two peptides of
1,420.747 Da and 1,422.766 Da, corresponding, respectively, to the
oxidized and reduced formof the peptide (Fig. 8, which is published
as supporting information on the PNAS web site). We tested the
reducing activity of AtCCMH in the insulin reduction assay (35).
Similar to its bacterial homologue RcCcl2 (18), AtCCMH (in
excess) was unable to reduce insulin in vitro (data not shown).
Taken together, these data show that D1-His cysteines could
interact with different biological disulfide reductants and the heme-
bindingmotif of an apocytochrome cmodel peptide, suggesting that
the RCXXC motif of CCMH can be functionally active in redox
processes needed for cytochrome c maturation.
Discussion
We report here the identification ofAtCCMH, a plant nuclear gene
ortholog of the ccmHcycLccl2 bacterial gene family of system I.
We have demonstrated that AtCCMH is a monotopic type I
membrane protein and that the conservedRCXXCmotif is located
in the intermembrane space where the assembly of c-type cyto-
chromes occurs. These characteristics are consistent with the con-
servation ofCCMHfunction in c-type cytochromematuration from
bacteria to plant mitochondria.
To study the function of AtCCMH in plants, we analyzed an A.
thaliana insertionmutant. Homozygote ccmhccmh embryos could
be obtained, indicating that the mutation is not lethal in either
gametophyte. However, such ccmh knockout embryos stop their
development at or before the torpedo stage. The absence of
morphologic defects in these dead embryos, together with the fact
that AtCCMH gene is expressed in all organs of the plant, indicates
that AtCCMH is an essential gene encoding a housekeeping func-
tion rather than a gene needed at a specific embryo developmental
step. We propose that the restriction of available holocytochromes
c and c1 progressively limits the flow of electrons through respira-
tory chain complexes III and IV, thereby decreasing ATP produc-
tion, which in turn affects chloroplast development as observed for
white ccmhccmh embryos.
AtCCMH was unable to replace EcCcmH for holocytochrome c
formation even though it was expressed and properly targeted to
the periplasm. In E. coli CcmH, an L to A mutation in the
LRCXXCQ motif found in nearly all bacteria CcmH proteins
abolishes the function (U.A., unpublished results). Similarly, the
absence of complementation could be attributed to the sequence
Fig. 5. Yeast two-hybrid assays with AtCCMH N-terminal domain (D1),
AtCCMH C-terminal domain (D2), and AtCYTc-a (C). (A) The domains or
proteins were fused to the activating domain (AD) or the DNA binding domain
(BD) of GAL4, cotransformed in yeast, and plated on different combinations
of drop-out medium-selective plates, i.e., minus leucine (L), tryptophane (W),
adenine (A), and histidine (H). (B) Liquid -gal assay using 2-nitrophenyl
-D-galactopyranoside (o-NPG) as a substrate. -Gal activity is expressed in U
(U  nmolmin). WT stands for WT pJ69-4A yeast cells. The values displayed
are the average -Gal activities for three individual double transformant or
WT cell colonies, with standard deviations indicated by error bars.
Table 1. In vitro reduction of DTNB-labeled D1-His
DTT
Reduction, %
NADPH  AtNTRB NADPH  GR
— PtTRXh1 PtTRXh2 GSH GSH  PtGRX
100 6 74 90 35 60
The N-terminal domain of AtCCMH containing the DTNB-oxidized RCXXC
motif was reduced by DTT, AtNTRB, NTR-reduced thioredoxin (PtTRXh1 or
PtTRXh2), GR-reduced glutathione (GSH), or GSH-reduced glutaredoxin
(PtGRX). The amount of TNB obtained after reduction with DTT was chosen
as 100%.
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divergence from bacteria to plant CCMH proteins, which share a
strictly conserved VRCTECG motif. Alternatively, the lack of
complementation could originate from a structural rather than an
enzymatic defect. A third explanation would be that plant mito-
chondrial CCMH have evolved a different function.
In bacteria, CcmH was proposed to have a structural role
together with CcmF in providing apocytochrome and heme in the
proper conformation for their ligation to occur. AtCCMH interacts
with EcCcmF in E. coli, although this interaction does not lead to
a functional complementation. In A. thaliana, the analysis of plant
mitochondria membrane complexes has shown that AtCCMH and
AtCCMFN2 can be associated in a 500-kDa complex of unkown
composition. Two-dimensional gels show that CCMH and CcmFN2
are also found in other complexes, not detected on the first
dimension most probably because of masked epitopes. The detec-
tion of both proteins in various complexes argues in favor of
transient interactions between CCM proteins. We propose that the
complex containing both CCMH and CcmFN2 in plants could hold
the heme lyase activity, as already suggested by other experiments
in bacteria (13).
As part of a heme lyase complex and as a reductant for
apocytochrome cysteines, AtCCMH is predicted to interact with
apocytochromes. In E. coli, neither successful coimmunoprecipita-
tion nor detection of mixed disulfides between CcmH and apocy-
tochromes has been reported (13). Similarly, AtCCMH and apo-
cytochrome c coimmunoprecipitation was unsuccessful in our
hands. Therefore, we used yeast two-hybrid assays more appropri-
ate for the detection of transient interactions. Indeed, the D1
domain of AtCCMH containing the RCXXC motif was found to
interact with AtCYTc-a, whereas the C-terminal domain of AtC-
CMH (located in the matrix) did not. Disulfide bond formation is
unlikely to occur in the reducing environment of the yeast nucleus
where the two-hybrid interaction takes place. This finding suggests
that the interaction between CcmH and apocytochrome could rely
on a non-disulfide mediated protein–protein interaction. Indeed,
CCMH could have a scaffold-like function for apocytochrome c.
In E. coli, in addition to CcmA-H proteins, holocytochromes c
formation required three periplasmicDsb oxidoreductases (14). No
orthologs of the thioredoxin CcmG or of the Dsb proteins could be
identified in plant mitochondria. Therefore, AtCCMH is so far the
only component of the putative reducing pathway of system I
identified in plant mitochondria. In bacteria, several lines of evi-
dence support a role of CcmH in a redox reaction (17, 18, 36). We
showed that the cysteines of D1-His can form disulfide bonds
accessible to different enzymatic reductants in vitro and that a
reduced form of D1-His is able to reduce an intra-disulfide bridge
in the heme-binding motif of a model peptide for apocytochrome
c in vitro. This finding is a good indication of the redox capacity of
AtCCMH.
The intermembrane space of mitochondria is believed to be a
reducing compartment where the cysteines of apocytochromes
should be preserved from oxidation after their import into mito-
chondria. This finding suggests that a reducing pathway for cyto-
chrome c might not be needed in mitochondria. However, a
mitochondrial FAD-dependent sulfydryl oxidase, ERV1, located in
the intermembrane space, has been described in yeast and A.
thaliana (37). It would be interesting to investigate whether ERV1
could catalyze the formation of a disulfide bond in apocytochromes,
thus making the reducing activity of proteins such as CCMH
necessary. Indeed, Cyc2p, a flavoprotein was recently shown to
interact with system III CCHL and proposed to be involved in the
redox chemistry of the heme lyase reaction in yeast mitochondria
(38). Further investigations of the function of CCMH might give
clues toward the understanding of the yet unknown mechanisms
controlling the intermembrane space redox state in mitochondria.
Altogether, our results enable us to propose a central role of
CCMH in plant mitochondrial cytochrome c maturation, probably
as part of a heme lyase complex that holds as well the activity of
reducing apocytochrome c.
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